Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney

Clinical Immunology

Volumn 145, Issue 3, 2012, Pages 201-208

  Suzuki, Eiji ^a   Karam, Eva ^a   Williams, Sarah ^b   Watson, Dennis K ^a   Gilkeson, Gary ^a,b   Zhang, Xian K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Glomerulonephritis; Infiltrations; Inflammatory chemokines; Transcription factors

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FLI 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GLOMERULONEPHRITIS; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DNA; ENDOTHELIAL CELLS; GENE EXPRESSION; GLOMERULONEPHRITIS; HETEROZYGOTE; HUMANS; KIDNEY; LUPUS NEPHRITIS; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-FLI-1; RNA, SMALL INTERFERING;

EID: 84867783643     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.09.006     Document Type: Article

References (51)

1. Mills J.A. Systemic lupus erythematosus. N. Engl. J. Med. 1994, 330:1871-1879.
2. Urowitz M.B., Gladman D.D. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology 2000, 39:238-244.
3. Singh S., Saxena R. Lupus nephritis. Am. J. Med. Sci. 2009, 337:451-460.
4. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 1985, 37:269-390.
5. Perry D., Sang A., Yin Y., Zheng Y.Y., Morel L. Murine models of systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 2011:271694-271713.
6. Perez De Lema G., Maier H., Nieto E., Vielhauer V., Luckow B., Mampaso F., Schlondrorff D. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 2001, 12:1369-1382.
7. Schiffer L., Sinha J., Wang X., Huang W., von Gersdorff G., Schiffer M., Madaio M.P., Davidson D. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 2003, 171:489-497.
8. Tesch G.H., Maifert S., Schwarting A., Rollins B.J., Kelley V.R. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J. Exp. Med. 1999, 190:1813-1824.
9. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
10. Anders H.J., Belemezova E., Eis V., Segerer S., Vielhauer V., Perez de Lema G., Kretzler M., Cohen C.D., Frink M., Horuk R., Hudkins K.L., Alpers C.E., Mampaso F., Schlondorff D. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J. Am. Soc. Nephrol. 2004, 15:1504-1513.
11. Tucci M., Barnes E.V., Sobel E.S., Croker B.P., Segal M.S., Reeves W.H., Richards H.B. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum. 2004, 50:1842-1949.
12. Watson L., Midgley A., Pilkington C., Tullus K., Marks S., Holt R., Jones C., Beresford M. Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Lupus 2012, 21:496-501.
13. Noris M., Bernasconi S., Casiraghi F., Sozzani S., Gotti E., Remuzzi G., Mantovani A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab. Invest. 1995, 73:804-809.
14. Watson D.K., Smyth F.E., Thompson D.M., Cheng J.Q., Testa J.R., Papas T.S., Seth A. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 1992, 3:705-713.
15. Ben-David Y., Giddens E.B., Letwin K., Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991, 5:908-918.
16. Hsu T., Trojanowska M., Watson D.K. Ets proteins in biological control and cancer. J. Cell. Biochem. 2004, 91:896-903.
17. Karim F.D., Urness L.D., Thummel C.S., Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., Maki R.A., Gunther C.V., Nye J.A., Graves B.J. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 1990, 4:1451-1453.
18. Papas T.S., Bhat N.K., Spyropoulos D.D., Mjaatvedt A.E., Vournakis J., Seth A., Watson D.K. Functional relationships among ETS gene family members. Leukemia 1997, 11:557-566.
19. Georgiou P., Maroulakou I.G., Green J.E., Dantis P., Romano-Spica V., Kottaridis S., Lautenberger J.A., Watson D.K., Papas T.S., Fischinger P.J., Bhat N.K. Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome. Int. J. Oncol. 1996, 9:9-18.
20. Zhang L., Eddy A., Teng T.T., Fritzler M., Kluppel M., Melet F., Bernstein A. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol. Cell. Biol. 1995, 15:6961-6970.
21. Zhang X.K., Gallant S., Molano I., Moussa O.M., Ruiz P., Spyropoulos D.D., Watson D.K., Gilkeson G. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J. Immunol. 2004, 173:6481-6489.
22. Mathenia J., Reyes-Cortes E., Williams S., Molano I., Ruiz P., Watson D., Gilkeson G., Zhang X.K. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clin. Exp. Immunol. 2010, 362:362-371.
23. van Beijnum J.R., Rousch M., Castermans K., van der Linden E., Griffioen A.W. Isolation of endothelial cells from fresh tissues. Nat. Protoc. 2008, 3:1085-1091.
24. Jackers P., Szalai G., Moussa O., Watson D.K. Ets-dependent regulation of target gene expression during megakaryopoiesis. J. Biol. Chem. 2004, 279:52183-52190.
25. Zhang X.K., Moussa O., LaRue A., Bradshaw S., Molano I., Spyropoulos D.D., Gilkeson G., Watson D.K. The transcription factor Fli-1 modulates marginal zone and follicular B cell development. J. Immunol. 2008, 181:1644-1654.
26. Zoja C., Liu X.H., Donadelli R., Abbate M., Testa D., Corna D., Taraboletti G., Vecchi A., Dong Q.G., Rollins B.J., Bertani T., Remuzzi G. Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J. Am. Soc. Nephrol. 1997, 8:720-729.
27. Tesch G.H., Schwarting A., Kinoshita K., Lan H.Y., Rollins B.J., Kelley V.R. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J. Clin. Invest. 1999, 103:73-80.
28. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004, 65:116-128.
29. Anders H.J., Belemezova E., Eis V., Segerer S., Vielhauer V., Perez de Lema G., Kretzler M., Cohen C.D., Frink M., Horuk R., Hudkins K.L., Alpers C.E., Mampaso F., Schlöndorff D. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J. Am. Soc. Nephrol. 2004, 15:1504-1513.
30. Rovin B.H., Rumancik M., Tan L., Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab. Invest. 1994, 71:536-542.
31. He X., Schoeb T.R., Panoskaltsis-Mortari A., Zinn K.R., Kesterson R.A., Zhang J., Samuel S., Hicks M.J., Hickey M.J., Bullard D.C. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J. Immunol. 2006, 177:8748-8756.
32. Diaz Encarnacion M.M., Warner G.M., Cheng J., Gray C.E., Nath K.A., Grande J.P. N-3 fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells. Am. J. Physiol. Renal Physiol. 2011, 300:1142-1151.
33. Giselle T.Y., Cheung A., Yaw L., Siow A., Karmin O. Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NF-kappaB activation. Can. J. Physiol. Pharmacol. 2008, 86:88-96.
34. Campbell S., Burkly L.C., Gao H.X., Berman J.W., Su L., Browning B., Zheng T., Schiffer L., Michaelson J.S., Putterman C. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J. Immunol. 2006, 176:1889-1898.
35. Yoshimura T., Yuhki N., Moore S.K., Appella E., Lerman M.I., Leonard E.J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989, 244:487-493.
36. Cho H.Y., Park C.M., Kim M.J., Chinzorig R., Cho C.W., Song Y.S. Comparative effect of genistein and daidzein on the expression of MCP-1, eNOS, and cell adhesion molecules in TNF-α-stimulated HUVECs. Nutr. Res. Pract. 2011, 5:381-388.
37. Famulla S., Horrighs A., Cramer A., Sell H., Eckel J. Hypoxia reduces the response of human adipocytes towards TNFα resulting in reduced NF-κB signaling and MCP-1 secretion. Int. J. Obes. 2011, 200:1-7.
38. Kawanami D., Matoba K., Kanazawa Y., Ishizawa S., Yokota T., Utsunomiya K. Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2011, 411:798-803.
39. Lee H.Y., Lee S.Y., Kim S.D., Shim J.W., Kim H.J., Jung Y.S., Kwon J.Y., Baek S.H., Chung J., Bae Y.S. Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells. J. Immunol. 2011, 186:4347-4353.
40. Yamaji-Kegan K., Su Q., Angelini D.J., Myers A.C., Cheadle C., Johns R.A. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism. J. Immunol. 2010, 185:5539-5548.
41. Galley H.F., Webster N.R. Physiology of the endothelium. Br. J. Anaesth. 2004, 93:105-113.
42. Danese S., Dejana E., Fiocchi C. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 2007, 178:6017-6022.
43. Zhan Y., Brown C., Maynard E., Anshelevich A., Ni W., Ho I.C., Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 2005, 115:2508-2516.
44. Page S.H., Wright E.K., Gama L., Clements J.E. Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One 2011, 6:e22052.
45. Panicker S.R., Sreenivas P., Babu M.S., Karunagaran D., Kartha C.C. Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1. Pharmacol. Res. 2010, 62:328-336.
46. Sutcliffe A.M., Clarke D.L., Bradbury D.A., Corbett L.M., Patel J.A., Knox A.J. Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1. Br. J. Pharmacol. 2009, 157:436-450.
47. Ito Y., Daitoku H., Fukamizu A. Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem. Biophys. Res. Commun. 2009, 378:290-295.
48. Kondo M., Maegawa H., Obata T., Ugi S., Ikeda K., Morino K., Nakai Y., Nishio Y., Maeda S., Kashiwagi A. Transcription factor activating protein-2beta: a positive regulator of monocyte chemoattractant protein-1 gene expression. Endocrinology 2009, 150:1654-1661.
49. Boekhoudt G.H., Guo Z., Beresford G.W., Boss J.M. Communication between NF-kappa B and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 2003, 170:4139-4147.
50. Hoffmann E., Ashouri J., Wolter S., Doerrie A., Dittrich-Breiholz O., Schneider H., Wagner E.F., Troppmair J., Mackman N., Kracht M. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J. Biol. Chem. 2008, 283:12120-12128.
51. Watson D.K., Robinson L., Hodge D., Kola I., Papas T.S., Seth A. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 1997, 14:213-221.